The Last Starship is a new comic series that puts a resurrected Captain Kirk in charge of a new ship with a new crew ...

A s Shazad Latif's Nautilus officially arrives 20,000 leagues below the 2025 TV schedule on AMC and AMC+, Star Trek: ...

Paramount+ has officially greenlit the fifth and final season of Star Trek: Strange New Worlds. But this isn’t just another renewal. It’s a signpost in the franchise’s legacy, one that says something ...

Paramount just canceled popular Star Trek series Strange New Worlds, but they did it by giving them two season renewals since the last episode aired.

Vienna-based startup chatlyn closed an $8.6 million Series A round led by London’s Smedvig Ventures, alongside angel investor Andreas Burike (AnyDesk), Austrian transport operator Blaguss, and other ...

SIR DAVE BRAILSFORD is set to step back in his role at Manchester United. The move comes as part of a major reshuffle being planned by Ineos head honcho Sir Jim Ratcliffe. According to The Times, B… ...

Sanofi is paying $129 per share in cash for Blueprint, amounting to a $9.1 billion equity value and a 27% premium on the biotech’s closing price on Friday.

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...

Sanofi announced that it will buy pharma company Blueprint Medicines for $129 per share, making the deal worth more than $9 billion. Blueprint specializes in systemic mastocytosis and other ...

Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare immunological diseases. Sanofi will pay $129 per share in cash for the US ...

In the realm where financial acumen blends with personal legacy planning, strategic philanthropy is offering the blueprint for modern wealth management. Today's billionaire donors are engraving ...

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Adds fast-growing and only approved medicine for advanced and ...